These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6182981)

  • 21. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination chemotherapy with bleomycin, vinca alkaloid and cisplatin (BVP) for advanced urothelial cancer].
    Sekine H; Fukui I; Yamada T; Takeuchi S; Tachibana Y; Yokokawa M
    Hinyokika Kiyo; 1984 Aug; 30(8):1095-9. PubMed ID: 6083719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
    Klener P; Donner L
    Acta Haematol; 1977; 57(5):272-8. PubMed ID: 66832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinblastine, bleomycin and cis-diamminedichloroplatinum in disseminated testicular cancer: response to treatment and prognostic correlations. A Southwest Oncology Group Study.
    Samson MK; Fisher R; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW
    Eur J Cancer (1965); 1980 Oct; 16(10):1359-66. PubMed ID: 6162646
    [No Abstract]   [Full Text] [Related]  

  • 25. Salvage therapy of aggressive non-Hodgkin's lymphoma with a combination of vinblastine, bleomycin, and cisplatin.
    Corder MP; Clamon GH
    Cancer; 1984 Jul; 54(2):202-6. PubMed ID: 6202388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of alanine-aminopeptidase and N-acetyl-beta-D-glucosaminidase during sequential combination chemotherapy.
    Diener U; Knoll E; Ratge D; Langer B; Wisser H
    J Clin Chem Clin Biochem; 1982 Sep; 20(9):615-9. PubMed ID: 6183389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
    Krikorian JG; Daniels JR; Brown BW; Hu MS
    Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
    Case DC; Young CW; Nisce L; Lee BJ; Clarkson BD
    Cancer Treat Rep; 1976 Sep; 60(9):1217-23. PubMed ID: 65221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
    Brice P; Colin P; Berger F; de Kerviler E; Diviné M; Bouaffia F; Kerneis Y; Blanc M; Lepage E; Fermé C;
    Cancer; 2001 Aug; 92(3):453-9. PubMed ID: 11505388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of malignant lymphomas.
    Bonadonna G
    Semin Oncol; 1985 Dec; 12(4 Suppl 6):1-14. PubMed ID: 2417334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
    Lokich JJ; Frei E; Jaffe N; Tullis J
    Cancer; 1976 Aug; 38(2):667-71. PubMed ID: 61797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
    Porzig KJ; Portlock CS; Robertson A; Rosenberg SA
    Cancer; 1978 May; 41(5):1670-5. PubMed ID: 77180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contribution of anthracyclines in treatment of lymphoproliferative disorders].
    Coiffier B
    Pathol Biol (Paris); 1987 Jan; 35(1):75-8. PubMed ID: 2436132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
    Bonadonna G; Zucali R; Monfardini S; De Lena M; Uslenghi C
    Cancer; 1975 Jul; 36(1):252-9. PubMed ID: 54209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
    Case DC
    Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination chemotherapy of disseminated non-seminomatous testicular cancer. Combined with cis-diaminodichloroplatinum, vinblastine and bleomycin therapy].
    Rørth M; Hansen M; Hansen HH; von der Maase H
    Ugeskr Laeger; 1980 Oct; 142(41):2691-3. PubMed ID: 6160668
    [No Abstract]   [Full Text] [Related]  

  • 39. MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
    Klimo P; Connors JM
    J Clin Oncol; 1985 Sep; 3(9):1174-82. PubMed ID: 2411881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin.
    Wittes RE; Yagoda A; Silvay O; Magill GB; Whitmore W; Krakoff IH; Golbey RB
    Cancer; 1976 Feb; 37(2):637-45. PubMed ID: 56214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.